Safety of SGLT2 Inhibitors in Three Chronic Diseases.
Sign Up to like & getrecommendations! Published in 2023 at "International heart journal"
DOI: 10.1536/ihj.22-441
Abstract: This study aimed to assess the safety of SGLT2 inhibitors in type 2 diabetes, chronic kidney disease, and chronic heart failure considering the number needed to treat (NNT).Methods: Data were obtained from 10 morbidity-mortality trials… read more here.
Keywords: safety; inhibitors three; kidney; safety sglt2 ... See more keywords